Avalyn Pharma Inc. ($AVLN)
Filing Information
| Accession Number | 0001193125-26-201894 |
|---|---|
| Form Type | 4 |
| Filing Date | May 1, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
38,914,842
Total Value
$5,000,004.00
P&L
+52.4% (+$2,619,446.54)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 1, 2026 | Conversion | 1,419,298 | โ | โ | 1,419,298 | Indirect | See Note 2 | View Details | |
Director | Common Stock | โ | May 1, 2026 | Conversion | 489,486 | โ | โ | 1,908,784 | Indirect | See Note 2 | View Details | |
Director | Common Stock | โ | May 1, 2026 | Purchase | 277,778 | $18.00 | $5,000,004.00 | 2,186,562 | Indirect | See Note 2 | View Details | |
Director | Series C-1 Convertible Preferred Stock | Derivative | May 1, 2026 | Conversion | 27,309,719 | โ | โ | 0 | Indirect | See Note 2 | View Details | |
Director | Series D Convertible Preferred Stock | Derivative | May 1, 2026 | Conversion | 9,418,561 | โ | โ | 0 | Indirect | See Note 2 | View Details |